Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Malvar, Jemily  [Clear All Filters]
Journal Article
Keller MD, Hanley PJ, Chi Y-Y, Aguayo-Hiraldo P, Dvorak CC, Verneris MR, Kohn DB, Pai S-Y, Saldaña BJDávila, Hanisch B, et al. Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment. Nat Commun. 2024;15(1):3258.
Parker RS, Le J, Doan A, Aguayo-Hiraldo P, Pannaraj PS, Rushing T, Malvar J, O'Gorman MR, Bard JDien, Parekh C. COVID-19 Outcomes in Children, Adolescents and Young Adults with Cancer. Int J Cancer. 2022.
Pommert L, Schafer ES, Malvar J, Gossai N, Florendo E, Pulakanti K, Heimbruch K, Stelloh C, Chi Y-Y, Sposto R, et al. Decitabine and Vorinostat with FLAG Chemotherapy in Pediatric Relapsed/Refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium. Am J Hematol. 2022.
Goldsmith KC, Park JR, Kayser K, Malvar J, Chi Y-Y, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, et al. Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. Nat Med. 2023.
Verma A, Chi Y-Y, Malvar J, Lamble A, Chaudhury S, Agarwal A, Li H-T, Liang G, Leong R, Brown PA, et al. Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium. Cancers (Basel). 2024;16(3).
Bhandari R, Aguayo-Hiraldo P, Malvar J, Cheng K, Sacapano A, Abdel-Azim H, Chi Y-Y, Wallace G, Asgharzadeh S, Jodele S, et al. Ultra-high dose vitamin D in pediatric hematopoietic stem cell transplantation: A nonrandomized controlled trial. Transplant Cell Ther. 2021.